著者
河野 英子 竹内 竜介 大沼 雅也 福嶋 路
出版者
横浜国立大学
雑誌
基盤研究(B)
巻号頁・発行日
2020-04-01

本研究は、新しい医療の制度化と国際的普及の事例分析を通じて、制度化過程とその変容を明らかにするものである。対象とするのは、自動体外除細動器(AED)を使用した一般市民による救命を意味する「市民による除細動(PAD)」である。PADの制度化と国際的な普及プロセスについて地域間比較を行う。多様な制度や組織・集団と関係する医療産業は、その重要性・特異性に比して社会科学的な研究が相対的に少ないなか、本研究成果は制度論に関する議論への貢献が期待できる。
著者
竹内 竜介
出版者
経営史学会
雑誌
経営史学 (ISSN:03869113)
巻号頁・発行日
vol.47, no.3, pp.3_32-3_57, 2012 (Released:2016-01-27)

management with a special reference to the FDI (i.e. foreign direct investment) from a historical perspective, especially from postwar period. The previous studies regarding the FDI for Japanese market has not fully captured in what ways the multinational enterprises strengthened the ties with Japanese market. It is also unclear how the enterprises have utilized the Social Capital in Japan.In pharmaceutical industry, for example, examining the relationship with Japanese medical practitioners is an extremely interesting question, especially if we view this under the management systems. The multinational pharmaceutical enterprises was urged to build up relation with Japanese medical practitioners and therefore made a good use of their network in order for the growth of their own business. Taking the above problems into consideration, the paper sheds a light on Schering AG of Germany as a case study and clarifies its management method in Japan between the 1950s and 1990s.Schering has strengthened the ties with Japanese subsidiary company since the late 1970s. The corporation tried to strengthen the functional capability of Japanese subsidiary by building up its R&D division as well as educating their employee. The Japanese subsidiary built up good relations with Japanese medical doctors who are supposed to contribute to acting as opinion leaders among Japanese medical circles. The subsidiary, in return, provides cutting edge scientific information to them.By utilizing Social Capital in contrast medium area, Schering had successfully expanded its Japanese market from 1980s. Then, it entered therapeutic medicine area in order to increase the profit. However, this was unsuccessful. This is because there had existed many related network of medical doctors in therapeutic medicine area already. It is also because that Schering has heavily relied on contrast medium business, which made it hard to make use of Social Capital and not succeed in this area.